Mesoblast Limited

MEOBF ·Healthcare, Drug Manufacturers - General, Australia
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $669.4M

Liabilities Breakdown FY2023

Total Liabilities: $167.6M